MLN0128 in Recurrent/Metastatic Merkel Cell Carcinoma
Status:
Completed
Trial end date:
2017-06-01
Target enrollment:
Participant gender:
Summary
This research study is studying a targeted therapy as a possible treatment for merkel cell
carcinoma.
- The name of the study intervention involved in this study is: MLN0128.